DDAVP: Does the drug have a direct effect on the vessel wall?

This publication has 16 references indexed in Scilit:

• DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand disease
  The Journal of Pediatrics, 1983
• Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia
  New England Journal of Medicine, 1983
• Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes
  Blood, 1982
• PLATELET‐VESSEL‐WALL INTERACTIONS: EXPERIENCES WITH VON WILLEBRAND PLATELETS*
  Annals of the New York Academy of Sciences, 1981
• Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease
  Thrombosis Research, 1981
• Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease
  British Journal of Haematology, 1981
• The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's Disease
  Scandinavian Journal of Haematology, 1980
• Vessel Wall Models for Studying Interaction Capabilities With Blood Platelets
  Seminars in Thrombosis and Hemostasis, 1978
• DDAVP: Alternative zur Substitutionsbehandlung bei leichter Hämophilie A und von-Willebrand-Jürgens-Syndrom
  Deutsche Medizinische Wochenschrift (1946), 1977
• 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE
  The Lancet, 1977